upcoming cryptocurrency to invest in 2021, Top

Hanyu Pharmaceutical Co., Ltd. signed a strategic cooperation agreement with Longma Technology. Recently, Hanyu Biotechnology (Dali) Co., Ltd., a subsidiary of Hanyu Pharmaceutical Co., Ltd., signed a strategic cooperation agreement with Longma Technology Group. The two sides will cooperate in the medical application of industrial cannabis and drug research and development around drugs and cannabinoids.The Taiwan Province Weighted Index closed down 221.45 points, or 0.96%, at 22,903.63 points on Wednesday, December 11th.A laboratory in Australia lost hundreds of deadly virus samples. It is reported that a laboratory in Australia lost hundreds of deadly virus samples, causing a "major loophole" in biosafety. On December 8th, Queensland Health Minister announced that there are currently 323 bottles of live virus missing. These include nearly 100 bottles of Hendra virus, two bottles of Hantavirus and 223 bottles of rabies virus-all of which are extremely deadly to human beings. The Queensland authorities insist that although these samples can be used as weapons, it is "not something that amateurs can do". The sample was lost in 2021, but investigators did not confirm the leak until August 2023. Queensland authorities waited for a year before being allowed to open the freezer where the samples were stored, and only this month were they able to confirm that the samples were lost. It is not clear where these samples may be or whether they have been destroyed. However, there is no evidence that the public is at risk of infection because of the disappearance of samples.

After 112 bids, part of the rights and interests of this 3A hospital in Chongqing were successfully auctioned at a price of 958 million yuan. The buyer was a Liaoning enterprise. On December 10, the auction of part of the rights and interests of the organizer of a 3A hospital in Chongqing, which had received much attention before, was finally sold at a price of 958 million yuan. According to the information of the judicial auction of Ali assets, the rights and interests of the organizer of the Third Affiliated Hospital of Chongqing Medical University (Jier Hospital) held by Chongqing Hanxin Hospital Management Co., Ltd. (hereinafter referred to as "the Third Affiliated Hospital of Chongqing Medical University") accounted for 65% of the rights and interests of the organizer. There were two bidders in the auction. The person in charge of Ali's asset-related business told reporters that many interested parties had consulted the platform before this auction. Although only two people signed up for this auction, the bidding process was fierce. Two bidders bid 112 times, and the bidding range was 3 million yuan each time. "The bidder with the final bid number of H0003 sold at a high price of 958 million yuan, which was 333 million yuan higher than the starting price. The premium rate of this auction reached 53.28%." The person in charge said. The "Confirmation of Successful Online Bidding" issued by Ali Assets shows that the bidder with the bidding number H0003 is named Liaoning Fangda Group Industrial Co., Ltd. In other words, this online auction was finally won by Liaoning Fangda Group Industrial Co., Ltd.. (Red Star News)Taobao responded to the netizen's 12 missing BMW cars: it's not fraud, it's really lucky. Recently, in the treasure-digging operation of Taobao Double 12, a 92-year-old girl from Shaanxi won a limited edition BMW motorcycle for 12.12 yuan. When interviewed, the girl said that she thought it was a model or a fraud, and she was worried that she had concerns without a driver's license. Taobao responded: "It's not fraud, it's your luck." He also expressed his willingness to add fire to the lucky young lady to go out and see, contract all the driver's license test fees and vehicle delivery fees, and ensure safety after the driver's license test. (Observer Network)Allan Monks, an economist in JPMorgan Chase: The Bank of England's signal about gradually cutting interest rates has been very strong recently, suggesting that the possibility of cutting interest rates next week is very low. However, if the signs of the accelerated weakening of the labor market continue, it will force the Bank of England's Monetary Policy Committee to deviate from this information.

Runyang's Jianhu 16GW N high-efficiency solar cell base resumed production. According to Runyang's WeChat WeChat official account news, on December 9, Runyang's Jianhu 16GW N high-efficiency solar cell base officially resumed production, which is another advanced solar cell base of Runyang in China since it resumed production in Qujing, Yunnan in October this year. It is reported that Runyang Jianhu production base is the largest single N-type battery production base in China at present, which has achieved full coverage of intelligent production and has an annual production capacity of 16GW of solar cells, and is committed to becoming one of the largest and most technologically advanced high-efficiency photovoltaic cell production bases in the world.The Nikkei 225 index just broke through the 39,300.00 mark, and the latest report was 39,302.42, down 0.17% in the day.CICC: Xiamen Tungsten Industry will be successfully issued, and resource development and high-end production capacity construction are expected to accelerate. According to the research report of CICC, Xiamen Tungsten Industry (600549.SH) will be successfully issued, and resource development and high-end production capacity construction are expected to accelerate. It is worth noting that the final issue price of this fundraising is 20.80 yuan/share, which is 28.87% higher than the reserve price, and 3.35% lower than the closing price of 21.52 yuan/share on November 6, the first day of the issuance period. After the completion of the issuance, the company is expected to accelerate the development of tungsten resources and the construction of downstream high-end production capacity, and strengthen profit growth. Considering the impact of stock issuance, the net profit of returning to the mother in 2024 will remain unchanged at 1.92 billion yuan, and the net profit of returning to the mother in 2025 will be raised by 1.7% to 2.25 billion yuan, and CAGR+18.6% from 2023 to 2025. Raise the target price by 17% to 24.1 yuan.